Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders

ULTIMATE I & II results: ublituximab versus teriflunomide in relapsing MS 3:27
ULTIMATE I & II results: ublituximab versus teriflunomide in relapsing MS
Lawrence Steinman • 11 Jun 2021
Tackling disease progression in MS 2:24
Tackling disease progression in MS
Nikolaos Grigoriadis • 8 Jun 2021
Palliative care improves QoL in advanced neurodegenerative disorders 4:46
Palliative care improves QoL in advanced neurodegenerative disorders
David Oliver • 11 Jun 2021
Surrogate markers of disease activity in MS 1:08
Surrogate markers of disease activity in MS
Dana Horakova • 2 Jun 2021
Low serum contactin-1 predicts disability progression in MS 4:27
Low serum contactin-1 predicts disability progression in MS
Charlotte Teunissen • 4 Jun 2021
Horizon scanning in treating disease progression in MS 2:27
Horizon scanning in treating disease progression in MS
Nikolaos Grigoriadis • 8 Jun 2021
Novel agents are needed for the treatment of multiple sclerosis 3:08
Novel agents are needed for the treatment of multiple sclerosis
Lawrence Steinman • 11 Jun 2021
Natalizumab improves mental and social health in a real-world MS cohort 3:53
Natalizumab improves mental and social health in a real-world MS cohort
Carrie Hersh • 3 May 2021
MS PATHS: clinical outcomes of underrepresented minority patients with MS 4:05
MS PATHS: clinical outcomes of underrepresented minority patients with MS
Carrie Hersh • 3 May 2021
The impact of the gut microbiota on clinical features in progressive MS 1:13
The impact of the gut microbiota on clinical features in progressive MS
Tanuja Chitnis • 26 Apr 2021
Addressing symptom management in MS 1:50
Addressing symptom management in MS
Carrie Hersh • 3 May 2021
Accelerating systematic learning with MS PATHS 3:42
Accelerating systematic learning with MS PATHS
Carrie Hersh • 3 May 2021
Severe COVID-19 in pediatric MS patients 1:11
Severe COVID-19 in pediatric MS patients
Tanuja Chitnis • 26 Apr 2021
Neurofilament light chain as a biomarker in pediatric MS 0:53
Neurofilament light chain as a biomarker in pediatric MS
Tanuja Chitnis • 26 Apr 2021
Managing pediatric MS in the current era 1:46
Managing pediatric MS in the current era
Tanuja Chitnis • 26 Apr 2021
Early predictors of long-term disability in pediatric MS 4:46
Early predictors of long-term disability in pediatric MS
Ermelinda de Meo • 23 Apr 2021
The content of VJNeurology is intended for healthcare professionals